Soleno Therapeutics (SLNO) Return on Assets Growth (3y) (2017 - 2026)

Soleno Therapeutics (SLNO) Return on Assets Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Soleno Therapeutics 2.74 Bn 2.49 Bn 93.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.00
Dec 31, 2025 2.00
Sep 30, 2025 0.00
Jun 30, 2025 -1.00
Mar 31, 2025 0.00
Dec 31, 2024 -1.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 -3.00
Jun 30, 2023 -3.00
Mar 31, 2023 -3.00
Sep 30, 2022 -1.00
Jun 30, 2022 -1.00
Mar 31, 2022 -1.00
Dec 31, 2021 -1.00
Sep 30, 2021 -2.00
Jun 30, 2021 -1.00
Mar 31, 2021 -1.00